All posts by admin

Business Wire India

ABS, through its affiliate ABSG Consulting Inc. (ABS Consulting), has today announced the acquisition of RMC Global (RMC), a leading provider of industrial cybersecurity, risk management and resiliency solutions.

 

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260430164690/en/

 

 

 

The acquisition strengthens ABS Consulting’s capabilities and market position, bringing together two organizations with complementary expertise, shared values and a common mission. Combining RMC’s capabilities with ABS Consulting’s scale, technical depth and global resources, unlocks more integrated solutions for clients operating in increasingly complex risk environments.

 

ABS Chairman and CEO John McDonald said: “Clients are facing increasing operational risk, cyber threats, and regulatory pressure. Bringing together the expertise of RMC and ABS Consulting strengthens our ability to deliver even greater value and support for our clients through comprehensive, integrated solutions.”

 

 

He highlighted that the acquisition is both a strategic and cultural fit. RMC’s strong culture of critical infrastructure protection and industrial cybersecurity aligns closely with ABS Consulting’s focus on protecting people, assets and critical operations around the world.

 

 

He said: “ABS and RMC make a strong fit in mission and culture. Both organizations are focused on work with real-world impact. Both value expertise, practical problem solving, and long-term trust. And both are committed to helping protect critical systems, support resilience, and solve complex challenges in environments where the stakes are high.”

 

 

ABS Consulting CEO David Wechsler said: “This acquisition builds on priority areas where we see sustained client demand and long-term growth opportunity. The combination strengthens our ability to support our customers’ evolving operational risk, cyber threats, and regulatory demands, while giving us a broader platform to deliver increasingly innovative solutions.”

 

 

RMC President Vince Kuchar said: “What brought our organizations together is a shared culture, mission, and purpose: delivering practical, trusted solutions that protect critical infrastructure and critical missions, enabling resilience in the face of growing risk. By joining ABS with its 164-year mission, we are better positioned to support our clients today and to adapt alongside them in the years ahead.”

 

 

More information about ABS Consulting is available here. More information about RMC is available here.

 

 

About ABS

 

 

ABS, a global leader in classification services, is focused on delivering a safer, cleaner future for the marine and offshore industries. For over 160 years, ABS has been setting standards for safety and excellence and continues to innovate in the fields of clean technology, digitalization and artificial intelligence, providing industry-leading technical advisory services. With a global network of surveyors, engineers, technology specialists and support staff, ABS works with industry leaders including its members and clients around the world to improve safety in operational performance and efficiency with innovative solutions for the complete life cycle of marine and offshore assets.

 

 

About RMC Global

 

 

RMC is a leading provider of industrial cybersecurity, risk management, and resiliency solutions for critical infrastructure and critical missions. Committed to safeguarding national security and resilience, RMC partners with government and commercial organizations to address evolving threats and vulnerabilities.

 

 

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260430164690/en/

 

Business Wire India

Masimo (NASDAQ: MASI) today announced the findings of a study evaluating the accuracy of Masimo SET^® pulse oximetry among critically ill neonates and demonstrating less than 1% overall statistical bias. Importantly, there were no clinically meaningful skin pigmentation-related discrepancies and no occult hypoxemic events among Black or Hispanic patients, and in only one Caucasian patient overall. The Neonatal Pulse Oximetry Accuracy and Disparities by Skin Pigmentation (NeoPODS) study findings were presented from the podium at the Pediatric Academic Society in Boston, MA on Monday, April 27^th at 10 am EST by lead author Dr. Heather Siefkes on behalf of colleagues at the University of California, Davis and the University of Mississippi, Jackson, alongside online publication in the Journal of Pediatrics. As the authors noted, “[W]e found no evidence of clinically meaningful skin tone-related discrepancies, suggesting equitable monitoring performance for this device in this clinical setting.”¹

 

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260428136753/en/

 

 

 

These promising results—from an NIH-funded study that exclusively evaluated Masimo SET^® in a vulnerable, clinically fragile patient population—add to previously published evidence of its strong performance under the most challenging real-world conditions across all skin tones. The INSPIRE feasibility study, published late last year, showed that SET^® pulse oximetry performed accurately on critically ill adult medical ICU patients of all skin tones, without any occult hypoxemic events²—results similar to the newly published NICU findings,¹ as well as prior evaluations of Masimo SET^®’s accuracy by skin tone.^3-6 The results of the full INSPIRE study—involving approximately 500 adult patients—are expected to be published later this year.

 

As Dr. Siefkes’ team points out, even when conducted prospectively, with real-world patients, past studies of pulse oximetry accuracy by skin tone in newborns have not used quantitative, objective measurements to classify pigmentation, or have other methodological shortcomings and limitations. Some prior studies have found that oxygen saturation measured by noninvasive pulse oximetry (SpO₂) can overestimate arterial blood oxygen saturation (SaO₂), which can lead to occult hypoxemia. Noting that accurate detection of hypoxemia is especially important in NICU patients, since it drives many care pathway decisions, the NeoPODS researchers thus set out to conduct a prospective accuracy study in this patient population, hospitalized NICU patients, with rigorous technical methodology: tightly paired, time-synchronized SpO₂-SaO₂ measurements and objectively classified skin pigmentation across a range of gestational ages using the same sensors and monitors for all patients. Their primary outcome was the mean bias between paired, simultaneously measured SpO₂ and SaO₂ values, and their secondary outcome, understanding how that bias differed by skin tone.

 

 

The researchers enrolled patients between July 2022 and July 2025 at two tertiary NICUs at UC Davis and UM Jackson. The patients were hospitalized newborns up to ten days old, of at least 26 weeks gestational age, with an indwelling arterial catheter and at least one clinically indicated arterial blood draw. Masimo RD SET^® Neo sensors connected to Radical-7^® Pulse CO-Oximeters^® and Root^® monitoring platforms were used to continuously record SpO₂ data before, during, and after arterial blood gas (ABG) sampling. SaO₂ values were directly measured with on-site laboratory analyzers and then paired with the corresponding average SpO₂ for the 30 seconds preceding each blood draw. In addition to recording parent-reported race, each patient’s skin tone classification was objectively assessed with a variety of methods, including melanin index and individual typology angle (ITA)—the latter a continuous, quantitative measure of skin pigmentation recommended by the FDA in their 2025 draft guidance for pulse oximeter manufacturers.⁷ Data was captured by a SkinColorCatch device, and visual scoring was performed by clinicians blinded to each other’s observations using the Massey-Martin and the Fitzpatrick scales.

 

 

From among 100 newborns enrolled over the three years, 136 paired SpO₂-SaO₂ readings collected from 70 patients met the technical criteria for inclusion in the final analysis. The patients’ median gestational age was 28.4 weeks and median gestational weight was 1085 grams (very low birth weight). As identified by their parents, 40% of the patients were Black and 23% were Hispanic. As objectively assessed, their skin pigmentations spanned the full range of ITA classifications and most, but not the darkest, points of the Massey-Martin and Fitzpatrick scales.

 

 

The researchers found that overall mean bias between noninvasive SpO₂ and invasive SaO₂ was -0.98% 2.80% (95% confidence interval, -1.45% to -0.52%), which is not a clinically significant amount, and means that, on average, SpO₂ slightly underestimated, not overestimated, SaO₂. In fact, there was only one data pair meeting the definition of occult hypoxemia (SaO₂<88% when SpO₂≥92%), collected from a patient with the lightest ITA skin tone classification; there were zero cases of occult hypoxemia among Black or Hispanic patients.

 

 

Turning to accuracy by skin pigmentation, the researchers found that across the objective classification measurements, as well as parent-reported race, there were no statistically or clinically significant differences in mean SpO₂-SaO₂ bias. For melanin index and ITA classification, when analyzed continuously, bias became slightly less negative with lighter skin pigmentation, but with statistical significance only when ITA analysis was restricted to each patient’s first measurement. There was no significant difference in bias comparing the 3 darkest to the 3 lightest ITA classifications, with all categories except the lightest showing a small negative bias and no statistically significant trend in bias with increasing darkness or lightness. Analyzing bias by Fitzpatrick and Massey-Martin classifications, the researchers similarly found no statistically significant differences (including when analysis was restricted to the first data pair per patient).

 

 

The authors concluded that their study is “a novel prospective study of newborns using objective skin pigmentation and closely paired SpO₂ and SaO₂ measurements assessing pulse oximeter accuracy across skin tones. Our study did not find clinically meaningful pigmentation-related bias. We believe this study provides some reassurance on equitable and accurate care in the NICU for this specific device and population. Our study supports the need for additional age-specific and device-specific pulse oximeter performance assessments.”

 

 

Heather Siefkes, M.D., Principal Investigator of the NeoPODS study and Associate Professor at the University of California Davis Children’s Hospital, commented, “In this prospective study of critically ill newborns with tightly paired measurements, we found that pulse oximetry only slightly underestimated arterial oxygen saturation overall and did not demonstrate clinically meaningful differences across skin pigmentation. Bias varied with oxygen saturation, with a tendency toward overestimation at lower SaO₂ levels; however, this pattern was not modified by skin pigmentation. Our findings highlight the importance of continued age-, disease-, and device-specific evaluation of pulse oximeter performance.”

 

 

Daniel Cantillon, M.D., Chief Medical Officer at Masimo, added, “Concerns about occult hypoxemia in vulnerable neonates, especially with darker skin tones, prompted this large, investigator-initiated and NIH funded real-world study applying rigorous scientific methods. Once again, we’re highly encouraged to see Masimo’s RD SET technology demonstrate less than 1% overall bias without occult hypoxemic events among Black or Hispanic infants. This is consistent with the recently published INSPIRE feasibility study results among critically ill adults in the ICU under similarly challenging conditions. However, as the authors note, these findings cannot be extrapolated to other pulse oximeter manufacturers untested on critically ill patients under real-world conditions.”

 

 

@Masimo | #Masimo

 

 

References

 

 

1. Siefkes H, Holla I, Giusto E, Tancredi D, and Lakshminrusimha S. Neonatal Pulse Oximetry Accuracy and Disparities by Skin Pigmentation (NeoPODS): A Prospective Study. J Ped. 21 Apr 2026. doi: 10.1016/j.jpeds.2026.115114
2. Travers A, Terry C, Merrell W, Heincelman M, Warden A, Goodwin A. INSPIRE: Feasibility of a Study Examining the Effect of Skin Pigment on Pulse Oximetry. CHEST Crit Care. 10 Sept 2025. DOI: 10.1016/j.chstcc.2025.100209.
3. Sharma V, Barker S, Sorci R, Park L, Wilson W. Racial effects on Masimo pulse oximetry: impact of low perfusion index. J Clin Monit Comput. 19 Jan 2024. https://doi.org/10.1007/s10877-023-01113-2.
4. Barker SJ, Wilson WC. Racial effects on Masimo pulse oximetry: a laboratory study. J Clin Monit Comput. 2023 Apr;37(2):567-574. https://doi.org/10.1007/s10877-022-00927-w.
5. Foglia EE, Whyte RK, Chaudhary A, Mott A, Chen J, Propert KJ, Schmidt B. The Effect of Skin Pigmentation on the Accuracy of Pulse Oximetry in Infants with Hypoxemia. J Pediatr. 2017 Mar;182:375-377.e2. https://doi.org/10.1016/j.jpeds.2016.11.043.
6. Marlar AI, Knabe BK, Taghikhan Y, Applegate RL, Fleming NW. Performance of pulse oximeters as a function of race compared to skin pigmentation: a single center retrospective study. J Clin Monit Comput. 2025 Feb;39(1):119-125. https://doi.org/10.1007/s10877-024-01211-9.
7. Pulse Oximeters for Medical Purposes – Non-Clinical and Clinical Performance Testing, Labeling, and Premarket Submission Recommendations. Draft Guidance for Industry and Food and Drug Administration Staff. January 7, 2025.

 

 

About Masimo

 

Masimo (NASDAQ: MASI) is a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, patient monitors, and automation and connectivity solutions. Our mission is for our innovations to empower clinicians to transform patient care. Masimo SET^® Measure-through Motion and Low Perfusion™ pulse oximetry, introduced in 1995, has been shown to outperform other pulse oximetry technologies in over 100 independent and objective studies, which can be found at www.masimo.com/evidence/featured-studies/feature. Masimo SET^® is estimated to be used on more than 200 million patients around the world each year and is the primary pulse oximetry at all 10 top U.S. hospitals as ranked in the 2026 Newsweek World’s Best Hospitals listing. Additional information about Masimo and its products may be found at www.masimo.com.

 

 

Forward-Looking Statements

 

 

This press release includes forward-looking statements as defined in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, in connection with the Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements other than statements of historical facts that address activities, events or developments that we expect, believe or anticipate will or may occur in the future. These forward-looking statements include, among others, statements regarding the outcome of future studies evaluating the real-world performance of Masimo SET^®; and other matters that do not relate strictly to historical facts or statements of assumptions underlying any of the foregoing. These statements are often identified by the use of words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “on-going,” “opportunity,” “plan,” “potential,” “predicts,” “forecast,” “project,” “seek,” “should,” “will,” or “would,” the negative versions of these terms and similar expressions or variations, but the absence of such words does not mean that a statement is not forward-looking. These forward-looking statements are based on current expectations about future events affecting us and are subject to risks and uncertainties, all of which are difficult to predict and many of which are beyond our control and could cause our actual results to differ materially and adversely from those expressed in our forward-looking statements as a result of various risk factors, including, but not limited to: the ability for clinical studies to recruit eligible participants; the ability for the investigator to collect meaningful data; the design of the clinical protocol; and other factors discussed in the “Risk Factors” section of our most recent periodic reports filed with the Securities and Exchange Commission (“SEC”), including our most recent Form 10-K and Form 10-Q, all of which you may obtain for free on the SEC’s website at www.sec.gov. Forward-looking statements are not guarantees of future performance. Although we believe that the expectations reflected in our forward-looking statements are reasonable, we do not know whether our expectations will prove correct. All forward-looking statements included in this press release are expressly qualified in their entirety by the foregoing cautionary statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today’s date. We do not undertake any obligation to update, amend or clarify these statements or the “Risk Factors” contained in our most recent reports filed with the SEC, whether as a result of new information, future events or otherwise, except as may be required under the applicable securities laws.

 

 

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260428136753/en/

 

Business Wire India

Merck Foundation, the philanthropic arm of Merck KGaA Germany, launched their Educating Linda Program to support girl education at Kenya State House, in partnership with H.E. Mrs. RACHEL RUTO E.G.H, The First Lady of the Republic of Kenya and Ambassador of “Merck Foundation More Than a Mother”. During the visit, the Merck Foundation Kenya Alumni Summit 2026 was also conducted to highlight the impact of their scholarships program with the aim to build healthcare capacity and transform patient care landscape across Kenya nationwide.

 

The program was attended by The First Lady of the Republic of Kenya H.E. Mrs. RACHEL RUTO E.G.H, Chairman of Merck Foundation Board of Trustees, Prof. Dr. Frank Stangenberg-Haverkamp, and CEO of Merck Foundation and President of “More Than a Mother” Campaign, Dr. Rasha Kelej and Kenya Minister of Health, Hon. Aden Duale.

 

Senator Dr. Rasha Kelej (Ret.), CEO of Merck Foundation and President of “More Than a Mother” Campaign, emphasized, “It is a great pleasure to meet my dear sister, H.E. Mrs. RACHEL RUTO E.G.H. First Lady of the Republic of Kenya and to recognize her for her tremendous efforts as the Ambassador of “Merck Foundation More Than a Mother”.

 

I am proud that through our long-term partnership we have provided 328 scholarships for young Kenyan healthcare providers in 44 critical and underserved specialties. I am also happy to share that nearly 50% of these scholarships have been awarded to women healthcare providers, reinforcing our commitment to women empowerment.

 

It was also great meeting Kenya Minister of Health, Hon. Aden Duale and our Alumni, who are the future healthcare experts of Kenya.”

 

“We are looking forward to extending our scholarship program to more healthcare providers in partnership with First Lady of Kenya and in collaboration with Medical Societies and Ministry of Health when possible.” She added.

 

H.E. Mrs. Rachel Ruto E.G.H., The First Lady of the Republic of Kenya, expressed, “Through our impactful partnership with Merck Foundation, we are not just implementing programs, we are transforming lives. Together, we are strengthening our healthcare capacity, empowering girls through education, breaking infertility stigma, and addressing other critical social and health challenges across Kenya. We are immensely proud that, through our strong partnership, we have been able to provide 328 scholarships for our healthcare providers, not only in the capital city, but across the country. It represents a powerful investment in the future of our healthcare system, a commitment to building expertise where it is needed most, and a significant step towards ensuring equitable access to quality care for all our people.

 

At the same time, we are equally proud to support the education of 47 high-performing yet underprivileged Kenyan schoolgirls, providing them with annual scholarships till they graduate. By empowering these young girls through education, we are not only transforming individual lives, but also shaping stronger families, communities, and a brighter future for our nation.”

 

Prof. Dr. Frank Stangenberg-Haverkamp, Chairman of Merck Foundation Board of Trustees, added, “Our aim is to improve the overall health and wellbeing of people by building healthcare capacity in Kenya and across developing countries. We are strongly committed to transforming patient care through our scholarships program.”

 

Hon. Aden Duale, Cabinet Secretary, Ministry of Health, Kenya, shared, “We sincerely appreciate the Merck Foundation Scholarships Program through which 328 scholarships have been provided till today for our local healthcare providers in many critical underserved specialties, helping us to build and strengthen our healthcare capacity, across the country.”

 

One of the important specialties that Merck Foundation is focusing on in 2025 and 2026 in Kenya is the scholarship of One Year Diploma in Nutrition, to support the program of Feeding and Food Security of Kenya First Lady.

 

More than 90 scholarships are dedicated to this specialty across the 47 provinces of Kenya. This will create a culture shift in leading a healthy lifestyle for the whole population which will contribute to healthier communities and hence social and economic development of the whole country nationwide.

 

The program was also attended by the Kenyan winners of Merck Foundation Media Awards 2024 and 2025.

 

“It was a pleasure meeting and celebrating our Winners, the health and social champions, who are the voice of the voiceless”, added Dr. Rasha Kelej.

 

Out of the total 328 scholarships, Merck Foundation has provided:

 

• 121 scholarships for one-year postgraduate diplomas and two-year master’s degrees in Diabetes, Preventative Cardiovascular Medicine, Cardiology, and Endocrinology. These programs enable doctors to establish specialized diabetes clinics across the country.
• 10 scholarships for Oncology, which is a critical specialty to strengthen cancer care capacity.
• 49 scholarships for Fertility, Embryology, and Reproductive Medicine under the “More Than a Mother” campaign, bringing hope and support to couples facing infertility challenges.
• 148 scholarships for other important specialties such as Internal Medicine, Psychiatry, Neurology, Emergency Medicine, Dermatology, and many more, contributing significantly to strengthening Kenya’s healthcare system.

Merck Foundation has overall provided more than 2,600 scholarships for healthcare providers in 44 critical and undeserved specialties from over 52 countries.

 

During the Summit, Merck Foundation alumni shared inspiring testimonies on how these scholarships have transformed their professional journeys and improved patient care in their communities.

 

Merck Foundation, in partnership with the First Lady of Kenya, is also launching children’s storybooks — “More Than a Mother”, “Educating Linda”, “Jackline’s Rescue”, “Not Who You Are”, “Ride into the Future”, “Sugar Free Jude” and “Mark’s Pressure” in English and Swahili to raise awareness about critical social and health issues among young children. Thousands of copies will be distributed across schools in Kenya. These storybooks have also been adapted into animated films to further enhance their impact.

 

Moreover, Merck Foundation has conducted 4 Editions of their Online Health Media Training for Kenyan journalists to empower them to raise awareness about sensitive social and health issues such as breaking infertility stigma, supporting girl education, ending child marriage and GBV, and promoting healthy lifestyle practices.

 

Merck Foundation, together with the First Lady of Kenya, also organizes annual awards for media, musicians, filmmakers, and fashion designers to encourage creative talents to raise awareness about important social issues.

 

Merck Foundation, in partnership with the First Lady of the Republic of Kenya has also announced the Call for Application for their 8 important annual Awards for Media, Musicians, Fashion Designers, Filmmakers, students, and new potential talents in these fields.

 

Details of the Awards:

1. Merck Foundation Africa Media Recognition Awards “More Than a Mother” 2026: Media representatives and media students are invited to showcase their work to raise awareness about one or more of the following social issues such as: Breaking Infertility Stigma, Supporting Girl Education, Women Empowerment, Ending Child Marriage, Ending FGM, and/ or Stopping GBV at all levels.

Submission deadline: 30^th September 2026.

 

2. Merck Foundation Film Awards “More Than a Mother” 2026: All African Filmmakers, Students of Film Making Training Institutions, or Young Talents of Africa are invited to create and share a long or short FILMS, either drama, documentary, or docudrama to deliver strong and influential messages to address one or more of the following social issues such as: Breaking Infertility Stigma, Supporting Girl Education, Women Empowerment, Ending Child Marriage, Ending FGM, and/ or Stopping GBV at all levels.

Submission deadline: 30^th September 2026.

 

3. Merck Foundation Fashion Awards “More Than a Mother” 2026: All African Fashion Students and Designers are invited to create and share designs to deliver strong and influential messages to raise awareness about one or more of the following social issues such as: Breaking Infertility Stigma, Supporting Girl Education, Women Empowerment, Ending Child Marriage, Ending FGM, and/ or Stopping GBV at all levels.

Submission deadline: 30^th September 2026.

 

4. Merck Foundation Song Awards “More Than a Mother” 2026: All African Singers and Musical Artists are invited to create and share a SONG with the aim to address one or more of the following social issues such as: Breaking Infertility Stigma, Supporting Girl Education, Women Empowerment, Ending Child Marriage, Ending FGM, and/ or Stopping GBV at all levels.

Submission deadline: 30^th September 2026.

 

5. Merck Foundation Media Recognition Awards 2026 “Diabetes & Hypertension”: Media representatives are invited to showcase their work through strong and influential messages to promote a healthy lifestyle and raise awareness about the prevention and early detection of Diabetes and Hypertension.

Submission deadline: 30^th October 2026.

 

6. Merck Foundation Film Awards 2026 “Diabetes & Hypertension”: All African Filmmakers, Students of Film Making Training Institutions, or Young Talents of Africa are invited to create and share a long or short FILMS, either drama, documentary, or docudrama to deliver strong and influential messages to promote a healthy lifestyle raise awareness about prevention and early detection of Diabetes and Hypertension.

Submission deadline: 30^th October 2026.

 

7. Merck Foundation Fashion Awards 2026 “Diabetes & Hypertension”: All African Fashion Students and Designers are invited to create and share designs to deliver strong and influential messages to promote a healthy lifestyle and raise awareness about the prevention and early detection of Diabetes and Hypertension.

Submission deadline: 30^th October 2026.

 

8. Merck Foundation Song Awards 2026 “Diabetes & Hypertension”: All African Singers and Musical Artists are invited to create and share a SONG with the aim to promote a healthy lifestyle and raise awareness about the prevention and early detection of Diabetes and Hypertension.

Submission deadline: 30^th October 2026.

 

Apply here: https://merck-foundation.com/Awards-Online-Application-Form

 

Entries for all the awards are to be submitted via email to:

submit@merck-foundation.com

Click the link below to Download Merck Foundation App

https://www.merck-foundation.com/MF_StoreRedirection

 

Join the conversation on our social media platforms below and let your voice be heard

Facebook: Merck Foundation
X: @MerckFoundation
YouTube: MerckFoundation
Instagram: Merck Foundation
Threads: Merck Foundation
Flickr: Merck Foundation
Website: www.merckfoundation.com

Business Wire India

inMorphis, a leading provider of enterprise risk and governance solutions, is proud to announce the appointment of Shantanu Srivastava to its Advisory Board.

A veteran risk leader with over 30 years of experience across premier financial institutions—including HSBC, SBI Card, Standard Chartered, and ANZ Grindlays—Srivastava will drive thought leadership and go-to-market (GTM) strategy for the company’s Risk and Security business.

The appointment comes at a time of growing convergence between Cyber and Operational Resilience — a shift that demands seasoned leadership with hands-on expertise in risk frameworks. Srivastava brings deep experience in implementing, upgrading, and scaling risk frameworks across India, the Middle East, and the Asia-Pacific region, equipping inMorphis with the strategic insight necessary to lead in the global Integrated Risk Management (IRM) and security space.

“Shantanu’s appointment marks a pivotal moment in our IRM journey,” said Himanshu Singhal, CEO of inMorphis. “His rare combination of strategic vision and hands-on execution across the world’s most respected financial institutions will be instrumental as we deepen our practice and expand our global footprint.”

Most recently, Srivastava served as the Chief Risk Officer at SBI Card, where he led enterprise-wide risk governance across all risks with an emphasis on credit, fraud, third party, cyber and other operational risk domains. His career also includes senior leadership roles at HSBC, where he embedded non-financial risk frameworks and led resilience transformation programs across the Asia-Pacific region, in line with global regulatory standards and international best practices. He is the Founding Regional Director of PRMIA (Professional Risk Managers’ International Association) and has lectured on Risk Management at globally renowned institutions including National Institute of Securities Markets (Mumbai), Columbia University (New York), Hindu College and IMI (Delhi).

Strengthening the Risk & Security Frontier

Srivastava’s arrival reinforces the inMorphis commitment to delivering adaptive, secure, and resilient business solutions. His core leadership experience includes:

• Operational Resilience and Governance: Bridging the gap between technical security domains and enterprise-level risk governance.

• Global Scale: Deep experience across diverse markets including India, Indonesia, Middle East and Asia Pacific.

• Sector Depth: Extensive knowledge of Retail Banking, Wealth Management, and Asset Management.

In his advisory role, Srivastava will work with inMorphis leadership to shape product strategy, support BFSI (Banking, Financial Services and Insurance) go-to-market initiatives, and advise on emerging risk domains.

 

“Risk management is no longer a mere regulatory obligation—it is a strategic imperative, a competitive advantage and an active enabler of resilient, scalable growth,” said Shantanu Srivastava. “I am excited to partner with inMorphis to help organizations build smarter, more adaptive risk, governance and security frameworks for today’s VUCA environment.”

 

Business Wire India

The LYCRA Company has appointed longtime executive Alistair Williamson as vice president of product sustainability, reaffirming its commitment to developing sustainable solutions for apparel and personal care products. In this role, he will guide the company’s next chapter of sustainability strategy and oversee all initiatives aimed at reducing environmental impact across products, operations, and innovation platforms.

 

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260430942396/en/

 

 

 

Williamson has four decades of experience in textile fibers and apparel, having held commercial, sales, and marketing leadership roles across EMEA, North America, and South Asia. Before joining the predecessor of The LYCRA Company in 2007, Williamson worked for two nylon spinners.

 

“Alistair’s expertise will drive our sustainability agenda and support our customers’ evolving requirements,” said Doug Kelliher, executive vice president, product. “His leadership will ensure we continue delivering high‑performance solutions with greater transparency and lower environmental impact.”

 

 

In recent years, The LYCRA Company has achieved several key sustainability milestones. These include launching Renewable LYCRA^® fiber with 70 percent plant-based content, introducing products made from recycled materials, and obtaining third-party certifications to promote transparency and traceability across the value chain.

 

 

“I’m honored to step into this role as our industry continues to shift toward more sustainable, transparent practices,” said Williamson. “I am committed to advancing sustainability as a shared priority across the organization, partnering closely with industry stakeholders, and driving meaningful, lasting outcomes.”

 

 

About The LYCRA Company

 

 

The LYCRA Company is a leading global fiber and technology solutions provider to the apparel and personal care industries, committed to offering sustainable products made with renewable, pre- and post-consumer recycled ingredients that reduce waste and help set the stage for circularity. Headquartered in Wilmington, Delaware, United States, it owns the LYCRA^®, LYCRA HyFit^®, LYCRA^® T400^®, COOLMAX^®, THERMOLITE^®, ELASPAN^®, SUPPLEX^®, and TACTEL^® brands. The LYCRA Company adds value to its customers’ products by offering unique innovations that meet the consumer’s need for comfort and lasting performance. Learn more at thelycracompany.com.

 

 

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260430942396/en/

 

Business Wire India

Riskified (NYSE: RSKD), a global leader in ecommerce fraud and risk intelligence, today announced the 2026 Titans of Ecommerce Awards, recognizing outstanding ecommerce leaders who are redefining fraud prevention while driving business growth.

 

The winners are:

 

 

• Titan of Americas: Joseph Chin, Senior Director of Revenue Assurance, Michael Kors
  Joseph Chin has evolved revenue assurance into a strategic lever for growth at Michael Kors. Deeply knowledgeable in fraud and payments, he maintains a hands-on approach, continually collaborating with Riskified to identify innovative opportunities, optimize performance, and pilot new initiatives. Joseph is highly effective at building internal alignment and securing stakeholder buy-in for new strategies. His leadership shone during Cyber Five, where his close collaboration with Riskified and real-time insights delivered one of Michael Kors’ strongest performance periods.

 

• Titan of Europe: Ash Cummings, Ecommerce Fraud Prevention Manager, Gymshark
  Ash Cummings is revolutionizing how Gymshark addresses fraud and policy abuse, transforming it into a strategic, data-driven discipline. He achieved significant reductions in promo, loyalty, and Item Not Received (INR) abuse, protecting both revenue and customer experience. This was accomplished by implementing advanced policy rules, integrating fraud intelligence into operational systems, and utilizing tools like Identity Explore to pinpoint abusive networks. Moreover, his work integrates fraud prevention with customer care and data analytics, enabling objective, data-backed decision-making at scale and enhancing Gymshark’s operational efficiency, especially during critical, high-demand product drops.

 

Now in its fourth year, the Titans of Ecommerce Awards honor members of Riskified’s global merchant community who are turning risk management into a driver of ecommerce performance. The program recognizes leaders who have delivered strong results navigating increasingly complex fraud environments through innovation, data-driven decisioning, and close collaboration with Riskified.

 

Winners of the 2026 Titans of Ecommerce Awards will be celebrated across Riskified’s global Ascend series. The two honorees, Titan of North America and Titan of Europe, will be showcased at their respective regional events: Ascend North America 2026, Riskified’s flagship summit taking place May 4-6 in New York City and Ascend Europe in London, June 15-16. Each winner will be featured and recognized in-region, highlighting their achievements within their local ecommerce ecosystems.

 

 

Award recipients are selected through a structured evaluation process assessing leadership in ecommerce fraud and abuse management, innovation in strategy and execution, measurable business impact, and effective utilization of Riskified’s AI platform and risk intelligence network. Nominees are evaluated based on outcomes such as fraud reduction, conversion and approval rate improvements, revenue growth, and operational efficiency.

 

 

This year’s awards are evaluated by a distinguished panel of industry experts spanning fraud prevention, payments, ecommerce, and technology, including Rahul Mutha, CEO of Aurus; Kevin Luh, Partner at Deloitte; Dan Beardall, Head of Partnerships at IXOPAY; Gabriel Le Roux, CEO of Primer; and Juan Pablo Ortega, CEO of Yuno. The panel brings together cross-industry expertise to ensure the selection of leaders who demonstrate both innovation and measurable impact across the ecommerce ecosystem.

 

 

“Each of this year’s Titans of Ecommerce faced complex fraud and risk challenges in very different environments, and still managed to improve outcomes across their businesses,” said Jeff Otto, Chief Marketing Officer at Riskified. “What stands out is not just the scale of what they were dealing with, but the way they approached it in practice. They made faster, more confident decisions, improved performance, and in many cases created smoother experiences for good customers while still protecting revenue. That balance between growth and risk is what really sets them apart this year.”

 

 

Ascend is Riskified’s global summit series for ecommerce risk management, bringing together leading merchants, fraud and risk executives, and technology partners across North America, Europe, Australia, China, and Japan. In 2026, the series will run under the theme “Intelligence in Motion,” exploring how AI, real-time intelligence, and agentic commerce are reshaping fraud prevention, checkout optimization, and digital commerce strategy.

 

 

For more information about Riskified’s Titans of Ecommerce Awards, visit https://www.riskified.com/titans/

 

 

About Riskified

 

 

Riskified (NYSE:RSKD) empowers businesses to unleash ecommerce growth by outsmarting risk. Many of the world’s biggest brands and publicly traded companies selling online rely on Riskified for guaranteed protection against chargebacks, to fight fraud and policy abuse at scale, and to improve customer retention. Developed and managed by the largest team of ecommerce risk analysts, data scientists, and researchers, Riskified’s AI-powered fraud and risk intelligence platform analyzes the individual behind each interaction to provide real-time decisions and robust identity-based insights. Learn more at riskified.com.

 

 

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260430017230/en/

 

Business Wire India

INOVUM Communication, a leader in integrated digital marketing, PR, and corporate gifting, today announced a definitive agreement with Defind Enterprises Private Limited, a prominent supplier of specialized systems and technical products for India’s Military and Para-military forces.

This collaboration positions INOVUM Communication to deploy its expertise in strategic digital communications and enhanced brand visibility to support Defind Enterprises’ mission of bridging procurement gaps, strengthening national defence capabilities, and contributing to India’s vision of Aatmanirbhar Bharat through indigenous solutions.

Defind Enterprises is also participating in the North Tech Symposium 2026, scheduled from May 4th to 6th in Prayagraj, Uttar Pradesh, where INOVUM Communication is the main digital and branding partner for the event.

Driving High-Impact Communication in a Critical Sector

The agreement focuses on leveraging INOVUM Communication’s data-driven approach to enhance Defind Enterprises’ brand narrative, media relations, and digital footprint. Key objectives of the partnership include:

• Strategic Media Relations: Securing high-profile coverage to highlight Defind Enterprises’ contributions to the Make in India initiative and its role in advancing defense indigenization.
• Digital Transformation: Implementing advanced digital strategies, including AI-driven content and marketing analytics, to optimize stakeholder engagement.
• Reputation Management: Strengthening the corporate reputation of Defind Enterprises as a trusted, innovative, and self-reliance-driven partner to the nation’s security forces.

“Partnering with Defind Enterprises is a privilege and a powerful testament to the impact of our integrated communication strategies,” said Vishwas Anjaneyaswamy, Director of INOVUM Communication. “The defence sector demands precision, trust, and clarity. We are committed to applying our innovative digital and PR expertise to amplify Defind’s critical role in strengthening India’s self-reliant defence ecosystem and technological excellence among key stakeholders.”

A Shared Vision for Excellence

Defind Enterprises chose INOVUM Communication for its proven track record in delivering measurable results and its ability to customize cutting-edge digital solutions. This collaboration reflects a shared commitment to excellence, national impact, and the broader vision of building a self-sustained defence infrastructure in India.

Dr. Shirish Gupte, Founder/Director at Defind Enterprises Private Limited, said, “As we continue to expand our portfolio of specialized systems aligned with India’s Aatmanirbhar Bharat vision, it is vital that our external communication reflects the same level of sophistication, reliability, and purpose. We are confident that INOVUM Communication’s strategic vision and deep understanding of the Indian market will be instrumental in achieving our communication goals.”

Business Wire India

Hilti India, in collaboration with Delhi Technological University (DTU), has strengthened its longstanding academia–industry partnership with the establishment of an industry-supported laboratory designed to build technical expertise among future engineers and advance its vision of Making Construction Better.

The collaboration is part of a sustained effort to build awareness and expertise in fastening technology, with a focus on enabling knowledge-sharing through structured technical sessions and experiential learning. Anchored in Hilti’s “Educate to Elevate” approach, the initiative reflects a joint commitment to bridging academia and industry — and to shaping a strong engineering community for the future.

The inauguration ceremony was presided over by the Hon’ble Vice Chancellor of DTU, with addresses from the Registrar, Head of the Department of Civil Engineering, Director of CoEDRR, and the Faculty Coordinator of CoEDRR. The proceedings underscored DTU’s and CoEDRR’s vision and initiatives, with particular emphasis on the role of applied research and industry collaboration in advancing engineering education.

The laboratory has been established with the vision of offering a structured and progressive learning journey for the engineering fraternity of tomorrow. It is designed to take students seamlessly through three distinct stages — from theoretical foundations through reference handbooks covering Steel-to-concrete and Concrete-to-concrete connections, to design and analysis using specialized software, and finally to real-world application through hands-on demonstrations with relevant tools and products.

With a focused emphasis on building competence in post-installed fastening technology, particularly for retrofitting and strengthening applications, the laboratory closely aligns academic learning with current industry requirements and real-world construction practices. The goal is to ensure that students are not just classroom-ready, but genuinely prepared to contribute to improved construction quality, enhanced jobsite safety, and the development of more resilient infrastructure across India.

Commenting on the initiative, Jayant Kumar, General Manager and Managing Director, Hilti India, said, “Engineering education is most powerful when it meets real-world application, and that is precisely the spirit behind our collaboration with Delhi Technological University. By equipping students with hands-on exposure to post-installed connections and modern construction technologies, we are investing in a generation of engineers who will build with greater precision, safety, and confidence. At Hilti India, everything we do is anchored in our purpose of Making Construction Better, and partnerships like this one are how that purpose comes to life, from the classroom to the job site.”

This initiative with DTU reflects Hilti India’s commitment to strengthening its engagement with engineering academia in India. Through partnerships that go beyond products and technology, Hilti aims to actively support how future engineers learn, think, and build. By expanding collaborations with leading institutions across the country, Hilti India is working toward integrating industry expertise with academic excellence, supporting the development of safer, more innovative, and sustainable construction practices in India.

 

Business Wire India

 

• Strong performance reflects sustained upward momentum driven by international expansion and operational efficiency
• Digital transformation initiatives in automation and artificial intelligence enhanced productivity, governance, and cost optimization

 

Estithmar Holding Q.P.S.C. announced its financial results for the first quarter of 2026, reporting a net profit of QAR 333 million, marking a significant 97% increase compared to the same period last year. The results underscore the strength of the Company’s operating model and the successful execution of its expansion strategy.

 

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429718889/en/

 

 

 

The company recorded revenues of QAR 1.455 billion, up from QAR 1.309 billion in Q1 2025. Gross profit rose to QAR 561 million compared to QAR 416 million, representing a year-on-year increase of 35%. EBITDA grew by 73% to reach QAR 473 million, while earnings per share increased by 90% to QAR 0.089.

 

These results reflect comprehensive growth across all key financial indicators, supported by a clear investment vision and the Company’s ability to balance geographic expansion, portfolio diversification, and operational efficiency. International investments announced in previous periods have begun to deliver tangible impact, contributing to revenue growth, enhanced profitability, and asset base expansion.

 

 

The strong growth in net profit is attributed to the Company’s disciplined approach to operational efficiency and value creation, alongside prudent capital management and effective risk management practices. In parallel, digital transformation initiatives, particularly in automation and artificial intelligence, have played a key role in improving productivity, strengthening governance, and optimizing costs.

 

 

The results also highlight a balanced contribution across the Company’s business Groups; healthcare, services, tourism and real estate development, and industries & specialized contracting, demonstrating each Group’s success in executing its growth strategy within an integrated strategic framework.

 

 

Commenting on the results, Juan Leon, CEO of Estithmar Holding, said:
“The Q1 results reflect the strength of our business model and our ability to deliver accelerated and sustainable growth simultaneously. This performance goes beyond achieving record figures, it demonstrates the quality of our investment decisions and disciplined execution across markets and sectors. The balance between revenue growth and improved profitability, supported by strong operational performance and healthy cash flows, highlights our efficiency and our ability to translate expansion into tangible shareholder value.”

 

 

Read More for the full Press Release

 

 

Source: AETOSWire

 

 

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260429718889/en/

 

Business Wire India

DC Administration Services, Inc. has today announced the composition of five regional Determinations Committees (DCs), effective from April 29, 2026.

 

Global Dealer Voting Members (for all Regions):		Non-Dealer Voting Members (for all Regions):
Bank of America, N.A.		Citadel Americas LLC
Barclays Bank plc		Elliott Investment Management L.P.
BNP Paribas		Pacific Investment Management Company LLC
Citibank, N.A.
Deutsche Bank AG
Goldman Sachs International
JPMorgan Chase Bank, N.A.
Regional Dealer Voting Member for the Americas, EMEA, Asia Ex-Japan, and Japan Determination Committees:		CCP Members for the Americas, EMEA, Asia Ex-Japan, and Australia-New Zealand Determinations Committees:
Mizuho Securities Co., Ltd.		ICE Clear Credit LLC
		LCH S.A.

 

The process for selecting DC members is specified in the DC rules. The DC rules, along with more information about the Determinations Committees and what they do can be found at the Determinations Committees website: https://www.cdsdeterminationscommittees.org/.

 

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260429009353/en/